title: [Treatment of venous thromboembolic disease in patients with cancer].
abstract: Results of classical anticoagulant therapy in cancer patients with venous thromboembolism (VT) are highly discussed. We retrospectively analysed the outcome of 43 patients with VT and cancer: 32% developed specific complications during either i.v. heparin therapy (10 +/- 0.9 days) or treatment by antivitamin K (106 +/- 14.9 days). Recurrence of thromboembolism (16%) and/or hemorrhages (16%) were much more frequent than in patients without cancer, underlying need for alternative therapy in cancer patients with VT.
authors.affiliation: Service de médecine interne, hôpital Saint-Louis, Paris.
authors.forename: D
authors.initials: D
authors.lastname: Farge
authors.forename: G
authors.initials: G
authors.lastname: Meyer
authors.forename: M H
authors.initials: MH
authors.lastname: Sayeg
authors.forename: P
authors.initials: P
authors.lastname: de Bourdeau
authors.forename: F
authors.initials: F
authors.lastname: Sauvaget
authors.forename: J
authors.initials: J
authors.lastname: Rouffy
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D012189:Retrospective Studies; D013923:Thromboembolism / Q000150:complications / Q000628:therapy*; D013997:Time Factors
vernacular_title: Traitement de la maladie thromboembolique veineuse (MTE) chez les patients cancéreux.